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Introduction 
The purpose of this thesis is to add to the data on the 
concentration of adrenal cortical hormones in human blood 
under various circumstances--with the ultimate goal of attempt¬ 
ing to understand the function of the adrenal gland so that 
man may apply this knowledge for the prevention and treatment 
of disease. Acute myocardial infarction was chosen as a 
stimulus in which to determine adrenal cortical response, 
because this condition represents an acute physiological 
emergency which usually can be accurately diagnosed and the 
time of onset fairly well determined. 
This study raises three types of problems. The first 
is to determine which compounds are the adrenal cortical 
hormones. For a compound to be considered an adrenal secre¬ 
tion it must be present in the adrenal venous blood in higher 
concentrations than in the peripheral venous blood, which is 
assumed to be equivalent in content to adrenal arterial blood. 
For an adrenal secretion to be considered a hormone, it must 
be active; that is, it must produce specific, repeatable 
physiological effects when administered in small amounts to 
humans. Hydrocortisone (cortisol) and corticosterone have 
been isolated and identified by strict chemical criteria in 
human adrenal venous blood in relatively high concentrations-- 
concentrations sufficient to produce the same physiological 
. '■ iO 
effects which occur when they are injected in pure form into 
humans. Hence they can he considered true adrenal cortical 
hormones. 
The second problem is that of devising accurate and 
specific methods to measure these hormones. The earliest 
methods of measuring the activity of the adrenal cortex 
utilized bioassay techniques based on the effects of the 
hormones on experimental animals. Later, after the hormones 
had been chemically identified and synthesized, chemical 
tests specific for a portion of the steroid molecule were 
used. These tests were first applied to urine because the 
concentration of the hormones or their metabolic products 
was higher in urine than in the peripheral blood. Later 
methods were developed for the extraction of the cortico¬ 
steroids from plasma and the efficient separation and isola¬ 
tion of individual steroids. When knowledge about the gross 
activity of the adrenal cortex is desired, the simplest 
techniques may suffice. However, when accurate measurement 
of the amounts of hydrocortisone per se and corticosterone 
per se are needed, more specific and hence more complicated 
methods involving separation and isolation of these cortico¬ 
steroids must be used. 
The third problem is to discover to what extent and 
under what circumstances an isolated plasma level of the 
hormone reflects the function of the adrenal cortex. The 
concentration of a substance in the blood depends upon the 
rate it enters and the rate it leaves the blood, assuming 
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the blood volume is constant. A single measurement of the 
plasma concentration of an adrenal hormone at a given moment 
does not necessarily reflect either the rate of its secretion 
or its rate of utilization. However, by determination of 
such isolated plasma values, we can calculate the rates of 
utilization of exogenously administered hormone under various 
conditions. Using this information about utilization, an 
estimate can be made of the rate of secretion of the hormone 
under similar conditions by measuring isolated endogenous 
peripheral venous blood levels rather than the continuous 
measurement of adrenal venous blood levels. 
The experimental evidence for these concepts and the 
rationale, methods, and results of studies of adrenal func¬ 
tion after myocardial infarction are presented in subsequent 
sections of this thesis. 
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Historical Background 
The earliest published description of the adrenals was 
written in 15(63, by Bartholomaeus Eustachius (11), who re¬ 
cognized their glandular structure and distinguished them 
from the perirenal fat. He called them the "glandulae 
renibus incumbentes" and henceforth their name has been some 
sort of description of their anatomic location. Thomas 
Bartholinis distinguished the adrenal medulla in l65l.(7) 
For about three hundred years nothing was known of the 
function of the adrenals. They were variously regarded as 
padding or support for other organs, fetal kidneys, recep¬ 
tacles for chyle, glands to absorb a Humour, ancillary parts 
of the gonads, or glands which functioned to prevent the 
formulation of renal calculi,(3) In 1716 the Academy of 
Science of Bordeaux offered a prize for the best thesis on 
the subject: "What is the function of the suprarenal gland?11. 
Montesquieu was appointed judge and, in his characteristic 
manner, exposed the sophistry of the essays and awarded no 
prize.(3) 
The first significant advance in the investigation of the 
function of the adrenals was the work of Thomas Addison, who 
described three cases of "idiopathic anaemia" associated with 
pathological changes of both adrenal glands.(5) He continued 
to study and delineate this syndrome, virhich has become known by 
his name.(6) 
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Greatly Influenced by Addison’s work, ^Brown-Sequard 
performed experiments indicating that bilateral adrenalectomy 
was fatal to experimental animals.(9) Attempts to reproduce 
his results, however, were complicated by the presence of 
accessory adrenal tissue and inexpert surgery; and it was 
not until the end of the ninet eenth century that the essen¬ 
tiality of the adrenals became acceoted.(12) Epinephrine 
was isolated and synthesized in the early 1900's, but it was 
soon evident that this hormone could not support life in 
adrenalectomized animals. 
Gaunt and Eversole have summarized the many early ex¬ 
perimental studies based on adrenalectomy, which recorded 
what is now known to be accurate information about adrenal 
cortical functions.(12) However, it was not until about 
1927-1930, when definitive evidence that the cortex secreted 
life-essential hormones was obtained, that the modern era of 
logical, systematic investigation of the adrenal cortex began,' 
In 1927, Hartman, e_t al. (1/+), showed that ox adrenal cortical 
extracts significantly prolonged the life of adrenalectomized 
cats. He called this essential hormone (s) "cortin". Also in 
1927* Rogoff and Stewart showed that "interrenalin", an extract 
prepared from dog adrenal cortices, prolonged the life of 
adrenalectomized dogs.(23) In 1929* methods were developed 
for preparing the first really potent cortical extracts (14,22, 
23), and Rogoff and Stewart published favorable results with 
the use of adrenal cortical extract in nine cases of clinically 
diagnosed Addison’s disease.(24) 
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Since 1930, there has been intensive research in this 
field, and many new adrenal functions have been discovered. 
Human urine was found to have adrenal cortical-like proper¬ 
ties. (21) The electrolyte changes in Addison's disease were 
rediscovered and studied.(10,13,18) The effects of the adrenal 
cortical hormones on carbohydrate metabolism were studied. (8, 
19) Selye emphasized the relation of the adrenal cortex to 
"stress", and defined and elaborated a concept of adrenal- 
mediated diseases (25)? which has stimulated much research. 
All of these early studies were based on methods utiliz¬ 
ing adrenalectomy or crude cortical extracts. A major advance 
came with the isolation of crystalline "cortin" in 1934*(17) 
In 1935? Steiger and Reichstein synthesized desoxycortico- 
sterone (27)? which was successfully used by Simpson In the 
treatment of Addison's disease.(26) When synthetic cortisone 
became available, It was discovered to be useful In the treat¬ 
ment In diseases seemingly unrelated to the adrenal, such as 
rheumatoid arthritis.(16) Most recently, aldosterone, the 
active principle of the amorphous fraction of cortical extracts, 
was Isolated and identified.(20) 
There have been numerous methods developed for measuring 
the physiological functions of the human adrenal cortex. Some 
methods attempted to quantitate the hormone level of the plasma 
by bioassay methods. (Lj_2,ij.7) Other methods measured the hor¬ 
mones by their effects on electrolytes or eosinophils (91,93) 
or by the chemical determination of the corticosteroid break¬ 
down products in the urine.(92) 
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The bioassay methods are useful as ways to define the 
effects of a hormone and to test the activity of pure com¬ 
pounds. However, "the chemical study of endocrine secretion 
plays an...essential role in endocrinology...by setting limits 
to speculation."(67b) The remainder of this paper will be 
concerned with the direct chemical methods of measuring the 
adrenal hormones themselves in the plasma, the evidence for 
the usefulness and accuracy of these methods, and the data 
obtained 
... iif OB 
- 
Review of Recent Literature 
Methods: 
Gold has recently published an excellent, detailed review 
of the methods for measuring plasma corticosteroids and the 
results of a number of clinical studies.(38) Gemzell(37) and 
Morris and Williams (J4.O) also give brief historical reviews of 
early methods. 
In 194-8 Corcoran and Page made the first attempt to 
measure the adrenocortical hormones in human peripheral blood 
by quantitative chemical methods, applying crude methods pre¬ 
viously used on urine.(35) Since then, there have been many 
methods, which usually have the following general steps: 
1. Extraction: of steroids from plasma or other fluids, 
removing lipids etc. 
2. Separation: of corticosteroids from each other and 
from other steroids. Wot all methods 
make such a separation. 
3. Identification: of a specific steroid by bioassay, 
rate of migration or other physical 
or chemical properties. 
4. Quantification: of the specific corticosteroid, usual¬ 
ly by using a color reaction and 
comparison with a known amount. 
5. Controls: of the above methods by parallel extrac¬ 
tions, colormetric blanks, use of dupli¬ 
cates, etc. 
Porter and Silber developed a color reaction useful for 
quantitating cortisone and related corticosteroids in 1950.(43) 
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Nelson and Samuels described the first practical method for 
extracting plasma and measuring the 17-hydroxysteroids using 
this color reaction. (41) In subsequent studies, hydrocorti¬ 
sone (cortisol) is tacitly assumed to be the only 17,21-dihy- 
droxy-20-ketosteroid measured. Bush, following methods of 
Zaffaroni and others (33,Ij.8), developed the use of paper chroma¬ 
tography to separate the s teroids. (34-) Abelson and Bondy used 
alkaline fluorescence with potassium-tert-butoxide as a method 
to quantitate delta-ij.-3-ketosteroids.(29) Sweat developed the 
use of sulfuric acid-induced fluorescence to measure steroids. 
(45) Bondy e_t al. , developed the use of labeled radio¬ 
active hormones to quantitate the hormone lost during the 
experimental procedures, and his paper(30) describes in detail 
the method used in this study. 
For details of the other methods of extraction, color 
reactions, controls, and quantification of corticosteroids, 
see Gold’s recent review(38) and the references at the end of 
this thesis.(References 29-48) 
Evidence for secretion of hydrocortisone (cortisol) and corti¬ 
costerone by the human adrenal: 
In 1953 Romanoff, jet al. , ( 92, S3, 76), published evidence 
for the isolation of hydrocortisone (Kendall’s Compound F) and 
corticosterone (Kendall’s Compound B) from human adrenal vein 
blood. In a patient undergoing adrenalectomy for carcinoma of 
the prostate and stimulated by ACTH, they obtained 500 ml. of 
adrenal venous blood. From this they Isolated enough of Com¬ 
pounds F and B to prove their Identity by melting-point 
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determination, infra-red analysis, ultra-violet absorbtion, and 
several color reactions. Several other biologically Inactive 
steroids with the A ring reduced--the tetrahydro-corticosteroids 
--were tentatively identified, but no cortisone was isolated. 
In a similar study on adrenal venous blood from a patient under¬ 
going adrenalectomy for carcinoma of the breast, identical 
results were obtained. This group of workers concluded that 
hjrdrocortisone is the predominant 11-oxy steroid in human 
adrenal venous blood. 
Bush(68) and Hudson and Lombardo(73) have also submitted 
evidence that the major plasma corticosteroid in humans is 
hydrocortisone. Sweat(86) has also summarized the evidence 
for the presence of Compounds F and B in human adrenal and 
peripheral venous blood and the evidence for those steroids 
which might possibly be present. Bush(67b) has summarized the 
experimental studies on the secretion of the adrenal cortex in 
animals and collected data on the ratio of F to B concentra¬ 
tions. Although he states that the F to B ratio may have no 
physiologic significance, he has stimulated efforts to deter¬ 
mine F/B ratio in humans. 
Data on adrenal function: 
Several authors have pointed out that an important 
problem in the study of plasma hydrocortisone and corticosterone 
concentrations is that of getting a method which is both simple 
and specific.(31*32) Many of the methods which are simple also 
have the difficulty of not separating and identifying compounds 
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P and B with certainty. Borth discusses the relative speci¬ 
ficity of six of the color reaction used and points out the 
virtue of paper chromatography in the separation step.(32) 
Using various methods of extraction and measurement, 
much data has been obtained in the past five years on the 
concentration of nonconjugated corticosteroids in humans 
under various physiological and pathological circumstances. 
In most studies, 17-hydroxycorticosteroids are tacitly as¬ 
sumed to be equivalent to hydrocortisone. Some of these 
results are summarized in the following paragraphs. 
Compound F (hydrocortisone): 
The values for hydrocortisone concentrations in normal 
subjects vary with the method used. See Table 1. for normal 
values using the method of Bondy, et al.,(30). In normal 
humans there is a diurnal variation in the 17-hydroxyeorti- 
costeroid concentration, with a peak in the morning(31,34-°* 
33,39) and also a normal day to day variation. (32) The level 
of 17-hydroxycorticosteroid rises gradually with pregnancy, 
probably due to placental secretion, and rises sharply in 
labor; but there is no change in the concentration in toxemic 
pregnancies. (IpO,4-9,34-^) 
ACTH stimulates a definite rise in 17-hydroxycorticosteroids 
in normals•(54->&4-*78) Pregnant patients and those with Cushing’s 
disease respond with an excessive rise of 17-hydroxycortico- 
steroid when given ACTH, while those with Addison’s disease, 
hypopituitarism and adrenogenital syndromes respond poorly or 
not at all,(34,78) 
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Emotional stress may elevate hydrocortisone levels 
slightly; "pre-operative tension,” twice normal; and operation 
itself, four times the normal. (55,61}.) 
The metabolism of hydrocortisone has been studied by 
administering the C1^-labelled hormone and following the 
radioactivity of the hormone and its metabolites in the plasma 
and as they are excreted in bile, urine and feces.(60,61,62) 
Hydrocortisone is reduced to the dihydro and tetrahydro forms 
and may become conjugated with one of several compounds-- 
primarily glucuronic acid.(60) The hydrocortisone glucuronides 
can be measured as the additional 17-hydroxycorticosteroid 
found after deconjugation with beta-glucuronidase.(1|6,83,88) 
Bongiovanni has asserted that under some clinical circumstances 
the level of conjugated corticosteroids (in spite of their lack 
of hormonal activity) may be more useful than that of free 
hydrocortisone. (31) 
In normal humans half of exogenously administered hydro¬ 
cortisone disappears in about onb to two hours.(60-62) In 
patients with cirrhosis of the liver, conjugation of hydro¬ 
cortisone is impaired.(6l,58) Hydrocortisone levels are ele¬ 
vated in dying patients, because of slowed removal rather than 
increased secretion, as there is still an increase after stim¬ 
ulation by ACTH.(36) Hydrocortisone utilization is faster in 
patients with thyrotoxicosis, slower In cases of myxedema and 
normal In patients with Addison’s disease.(6l) 
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C-old has recently reviewed much of the published work 
on plasma 17-hydroxycorticoids in newborns, children, preg¬ 
nant women, liver disease, surgical studies, various endo¬ 
crinological conditions, and the use of ACTS as a test of 
adrenal function. (38) 
Compound B (corticosterone): 
Compound B is present in human plasma in smaller amounts 
than Compound F( 67a,67b,78>82,86), and the detection and 
measurement of B requires procedures much more complicated 
than the measurement of 17-hydroxycorticosteroids. Hence 
much le33 is known about the stimulus, function, and metaboli 
fate of corticosterone. 
Infusion of C^-labelled corticosterone into humans has 
indicated that it is more rapidly conjugated to its glucuro- 
nides than hydrocortisone and is excreted to a relatively 
greater extent in bile.(82) Because Compounds F and B differ 
in their rate of disappearance from the blood stream and the 
plasma B levels are changing more rapidly than the F levels, 
the plasma F/B ratio is relatively useless as a guide to the 
relative rates of secretion of these two hormones. The vari¬ 
ability of the human F/B ratio reported by various authors 
(67a-38) seems to refute Bush’s suggestion that this ratio is 
a constant.(67b) 
Studies using experimental animals must be Interpreted 
with the knowledge that there is a marked species variation 
in the secretion and metabolism of corticosterone.(67b) 
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Corticosterone is the predominant corticosteroid secreted by 
rabbits, and rats apparently secrete no hydrocortisone at all. 
(67b) It is not surprising that ACTH stimulates corticosterone 
secretion in species which secrete no hydrocortisone. (84.,8£) 
The utilization of corticosterone in rats does not seem to be 
increased by stress.(8?) 
Bondy has shown that exogenous ACTH does raise plasma 
corticosterone levels in humans in most cases,(67a) but the 
primary endogenous stimulus for secretion of this hormone by 
humans has not yet been clearly established; because this 
hormone has not been adequately studied in clinical situations. 
Other data obtained from experimental animals have not 
yet been confirmed in the human. Compound B, like Compounds 
A and P, leads to increased fat deposition in chicks and mice. 
(71,77) While Compound P decreases resistance and lessens the 
immune response to certain infectious diseases in rabbits. 
Compound B does not have these effects#(79) Compound B secre¬ 
tion is less well sustained than the P secretion during 
hemorr*thagic shock in dogs; and low B levels may be associated 
with high P levels in an inverse dissociation, according to 
adrenal venous cannulation studies in dogs.(73,74-) 
A final criticism is that not all the methods used to 
measure corticosterone are accurate and specific(73>88) and 
data obtained by such methods must be confirmed by more precise 
methods. 
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The Adrenal Cortex and Acute Myocardial Infarction 
The most comprehensive study of the function of the 
adrenal cortex In the early phases of acute myocardial Infarc¬ 
tion was published by Porssman in 1954*(92) He summarizes the 
earlier investigation of this problem, all of which utilized 
eosinophil counts or measurement of urinary steroids. The 
studies of urinary steroids are few, but in general, show an 
increased urinary excretion of corticosteroids in the early 
stages of cardiac infarcts. Other studies utilizing eosino¬ 
phil counts agree that there is often an initial eosinopenia 
in infarcts, but there have been conflicting opinions concern¬ 
ing the diagnostic and prognostic value of this method.(91?93) 
Porssman studied 100 men and 3^ non-diabetic women with 
EKG-proved acute myocardial infarctIons.(92) He found a 
marked eosinopenia within 12 hours, followed by a gradual 
increase to normal values from the second to the eighth post¬ 
infarct day. He realized that adrenalin could cause an eosino¬ 
penia in the absence of adrenal cortical hormones, as shown by 
Thorn in studies on patients with Addison’s disease.(28) 
However, he argues that in his series the eosinopenia did 
represent an increase in circulating adrenal corticosteroids 
because parallel measurement of the adrenalin and nor-adrenalin 
in the urine showed that the secretion of these adrenal medul¬ 
lary hormones in his series of infarcts was not enough to produc 
eosinopenia. 
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Forssman also found the urine glucocorticoids and 17- 
ketosteroids were double the normal amount on the first day 
after the infarction, falling gradually to normal values by 
the sixth day. He found no correlation between the degree 
of eosinopenia and. the white blood cell count or temperature 
curves. He found a greater and more persistent eosinopenia 
/ 
in the 1+2 fatal cases than in the non-fatal cases. 
There have been few published studies before 1957 which 
record the plasma level of hydrocortisone following acute 
myocardial infarction and apparently none which measured the 
plasma level of corticosterone. 
Oka(9i|.,95) measured serial plasma 17-hydroxycorticoster- 
oids between 8 and 9 a.m,, using the Porter-Silber technique 
in 12 cases of myocardial infarction, 9 cases of stenocardia 
(angina pectoris), and 21 cases of cerebral vascular accidents 
He found the mean 17-hydroxycorticoidsteroid level was twice 
normal on the second day of infarction and fell to normal 
levels between the l5th and 22nd day. He found the mean 
hydrocortisone level in angina pectoris was l|r times normal 
on the day after the attack and was normal by the 15th 
day. The mean values in cerebral vascular accidents were 
higher, being 3 times normal. 
However, like the eosinophil studies, he found an occa¬ 
sional very low response by the adrenal cortex. Oka concluded 
that plasma F levels were not significantly useful in differen 
tiating myocardial infarction and simple angina pectoris and 
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postulated that pain and fear were as important as myocardial 
damage as factors in producing elevated hydrocortisone levels. 
Engel(89,90) measured serial eosinophil counts and serial 
17-hydroxycorticos teroids by the Nelson and Samuels (ij.1) method 
in 5 EKG—confirmed cases of acute myocardial infarctions, 3 
cases of angina pectoris and 9 other acute clinical situations 
He found very high values in the early hours after infarction- 
up to 5 times(J) the normal or convalescent values. 
The studies previously cited and this thesis are stimu¬ 
lated by essentially the same questions: To what extent does 
the "stress" of an acute myocardial infarction stimulate 
adrenal cortical activity? Are the adrena.l cortical functions 
correlated with any other observations noted in this condition 
This paper utilizes the timing of measurements suggested by 
the earlier studies, but in addition, an attempt is made to 
distinguish the functions of corticosterone and hydrocortisone 
by separate measurement. 
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Methods and Experimental Procedures 
Selection of patients; 
Over a three month period, all patients admitted to the 
New Haven Unit ward service of the Grace-New Haven Community 
Hospital with an admitting diagnosis suggestive of possible or 
probable acute myocardial infarction were screened as possible 
cases. Because the blood specimens were not obtained until 
the first morning after admission, patients who died within 
2l| hours after admission' were not included in this study. 
In three months of new admissions, only one patient who sur¬ 
vived myocardial infarction for 21+ hours after admission was 
known to have been omitted--because he was accidently over¬ 
looked until 5 days after admission. 
Eleven cases of acute myocardial infarction were studied. 
Seven of the ten control cases were thought to have possible 
infarctions on the morning after admission, and two cases were 
selected as examples of acute chest pain which were probably 
not due to myocardial infarction. The other control case was 
selected because of the presence of anoxia, cyanosis, and shock® 
The criteria for acute myocardial infarction were 1) a 
probable clinical diagnosis of myocardial infarction and 2) 
two or more serial EKG's showing typical evolution of an infarct- 
as read by the cardiology staff. Those patients classified as 
"acute coronary insufficiency" had a clinical diagnosis of 
. 
. 
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possible op probable myocardial infarction, EKG evidence 
consistent with myocardial ischemia, but no typical evolution 
of an infarct on three or more serial EKG's. 
Technique of measurement: 
The details — including reagents, sources of error, accu¬ 
racy and rationale--cf the techniques which were used to 
measure plasma hydrocortisone and corticosterone in these 
cases have been described in detail by Bondy, ejfc al., (67a); 
and so only the broad outline will be given here. 
It was decided to draw the samples for determination at a 
fixed time of day, because of the diurnal variations which had 
been previously noted.(5l>55>59) The hours between 9 and 11 
a.m. were chosen because the normal values in this laboratory 
had been obtained at about this time, and this also allowed us 
to get fasting specimens. Convalescent specimens were obtained 
at the same hour as the first specimen. 
Eighty to one hundred ml, of blood were obtained from the 
antecubital vein in a heparinized syringe, centrifuged immedi¬ 
ately, and the plasma frozen. The plasma was thawed within 
two months and the hormones then measured immediately. 
Duplicates were measured whenever there was more than a 
total of 25 ml. of plasma available; i.e., in all but 2 cases. 
In a few other cases only one of the duplicates was techni¬ 
cally satisfactory. The followring is a description of the 
experimental processing of a single plasma specimen. 
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A known amount of C^-labelled hydrocortisone and C1^- 
labelled corticosterone is added to the plasma, followed by 
0.5 ml. of IN. NaOH. The mixture is stirred and promptly 
extracted three times with redistilled chloroform. The corti¬ 
costeroids in the chloroform extract are separated by their 
distinctive rates of migration on filter paper in a ?0>£ meth¬ 
anol-toluene paper chromatography system. The point to which 
the unknown amounts of Compounds F and B have migrated is 
measured as the same distance a known control spot of F and B 
has migrated--this control spot being recognized by its ultra¬ 
violet fluorescence. The spots of Compounds F and B from the 
plasma, extract are then each cut out and eluted from the paper 
into ethanol. The ethanolic eluate is evaporated to dryness. 
An organic base (potassium tert-butoxide) is added and the 
fluorescence of each hormone compared to a standard curve- 
utilizing a Farrand fluorometer. Thus the hydrocortisone or 
corticosterone extracted from the plasma can be quantitated. 
The proportion of each hormone which was lost in the pro¬ 
cess of extraction and separation can be determined by compar¬ 
ing the radioactive labelled hormone recovered in the ethanolic 
eluate to the original labelled hydrocortisone or corticoste¬ 
rone added, by the use of a scintillation counter. It is 
assumed that the added labelled hormone and the hormone present 
originally are lost in the same proportion during the extrac¬ 
tion and elution. 
Before using the technique on samples of patients' blood, 
practice determinations were done on samples of plasma with 
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known amounts of added labelled hydrocortisone and cortico¬ 
sterone until about 7%% of the radioactive steroid was re¬ 
covered and there was close agreement of duplicate values. 
. 
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Clinical Summaries 
The hospital record unit-numbers are given in parentheses, 
following the patient’s initials. All significant clinical 
and laboratory data at the time the blood was drawn are listed. 
The adrenal cortices were within normal limits in all autopsied 
cases. All temperatures were taken rectally. 
Acute myocardial Infarctions: 
1. I.B.(87942), was a 73 year old blind white man with a 
history of angina for 5 years and auricular fibrilla¬ 
tion for 2 years. Two weeks before admission he devel¬ 
oped an increasing need for nitroglycerin. lie then had 
severe oppressive chest pain unrelieved by nitroglycer¬ 
in, profuse sweating, and a relative fall in blood 
pressure. Admission EKG showed a wandering pacemaker 
and serial EKG-’s showed the evolution of a posterior- 
lateral infarct. He had no fever or leucocytosis at 
anytime during his hospital course, and was discharged 
after 2£ days. 
F=19.7; 3=2.8: 26 hours after onset of pain, while 
patient was in O2 tent. 
PslS.l; B=3*S: 13 days after onset of pain. Good 
clinical condition. 
2. T.3.(27670) was a 43 year old Negro man with no history 
of heart disease. Three days before admission he had 
severe, crushing substernal pain and stopped work, went 
home, and rested. One'hour before admission he had a 
similar pain, radiating to the neck and left arm, weak¬ 
ness, profuse sweating, and relative hypotension. His 
blood pressure fell to 50 by palpation, but his pulse 
never rose above 80. He had no other signs of shock. 
By the 10th hospital day his blood pressure was 110/70 
and remained at that level until his discharge on his 
21st hospital day. He never had a leucocytosis, but his 
fever reached a peak of 102° on the 2nd day. Serial 
EKG1s showed evolution of a posterior-septal infarct. 
Serial measurement of transaminase and lactic dehydro¬ 
genase showed a peak on the 3rd hospital day. 
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2. T.B.(27670) con’t. 
Fsl2.5; 3=3.6: lLj. hours after 2nd pain, appearing very 
acutely ill. Pulse was 80. B.P. was 
50 by palpation. 
F=6.9; B=10.3: 10 days after admission, in good clini¬ 
cal condition, 
3. F.J.(452180) was a 63 year old white man with angina 
for 6 years and was admitted because of 4- episodes of 
severe angina in one day. He had intermittent fever 
up to 101° for the first 10 days. On the 10th day he 
developed severe chest pain and EKG’s (previously normal) 
showed acute posteriolateral infarction. A typical evolu¬ 
tionary pattern and right bundle branch block developed. 
Ho fever or leucocytosis developed and he was discharged 
after 27 days in the hospital. 
F=l4.6; B=0.9>5 3 hours after pain and EKG changes. 
Patient appeared well. 
FB=0: 11 days after this attack; good clini¬ 
cal condition. 
4* W.K.(450991)> a 37 year old white conductor, had angina 
for 4 years and a proved myocardial infarction 4 months 
previously. He had typical chest pain, shock, leucocy¬ 
tosis, fever up to 103° on the 3^d day, and evolution of 
a posterior infarct by serial EKG’s. His course was 
marked by a. pleural effusion, occasional vomiting and a 
varying heart block. He was discharged against advice 
on the 12th day. 
F=37.9; 3=5.6: 24 hours after onset of pain; acutely ill; 
B.P. was 120/100 on IV nor-epinephrine, 
In 02, temp=101°. 
F=17.2; B=5.4: 12 days after onset, in good clinical 
condition and afebrile. 
5. R.E.(A97323)s a 66 year old white man, had a similar 
attack 1 year ago, but the EKG was ambiguous. While 
walking, he had severe substernal pain, severe dyspnea, 
profuse sweating, and was given Op by firemen. On 
admission he had hypotension, basilar rales, and WBC 
of 12,000. EKG showed an old posterior infarction and 
acute anterioseptal infarction, but evolving pattern 
was obscured by old infarction. He had no fever through¬ 
out his 21 day course, 
F=8.2; Bsl.7: 26 hours after onset of pain. Good clini¬ 
cal condition. 
F=7.5; B=0: 13 days after onset, in good clincal 
condition. 
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6. F.M.(C34889), a 54 year old obese white man, had hyper¬ 
tension for 9 years, and an anterior myocardial infarc¬ 
tion 6 years previously, followed by dyspnea on exertion, 
orthopnea, periodic ankle edema and angina ever since. 
He had a sudden onset of severe substernal and left 
shoulder pain, nausea, sweating, increased dyspnea, and 
relative hypotension. His 27 day course was marked by 
leucocytosis up to 14*00 on the 3rd day, rectal tempera¬ 
ture peak of 100° on the 2nd day, and EEG’s showing LVH 
and evolution of an acute posterior infarction. Butanol 
extractable iodine ¥/as 3.1 micrograms %; total choles¬ 
terol was 308 mg.% of which 2Q% was free cholesterol. 
Patty acids were 18 mg.$. 
P=17.0; B=3.3: 5 hours after onset of pain. He was 
slightly dyspneic and had basilar rales. 
F=9.9; B=2.3: 13 days after onset of pain, in good 
clinical condition. 
7. A.Mc.(B78290-Autopsy 12102), a 68 year old white woman 
had a 5 week history of angina, which was worse on the 
day of admission. She had a knife-like pain in the chest 
both arms, sweating, and a feeling of impending death. 
EKOr showed an acute anterior infarction. WBC was 15,000 
on the 2nd day; the fever peak was 101.5° on the 2nd day. 
Her 29 day course was complicated by episodes of ventri¬ 
cular tachycardia and premature beats, treated with 
quinidine and pronestvl, and a hypotensive episode on 
the 2rd day which responded to IV fluids. She died 
suddenly on the 29th day, probably because of ventricular 
fibrillation. Autopsy was unremarkable except for organ¬ 
izing infarct and recent thrombus in the coronary arterial 
branch supplying the area. 
Fs35<>3* B=:5.2: 14 hours after onset of pain, in 02, 
occasionally vomiting. 
F=27.9; B=0.6: 24 days after onset, in good clinical 
condition, 1 day before she had a return 
of vomiting and daily fever spikes, which 
continued until her death. 
8. P.Mc.(B7829O), was a 37 year old white man who had had 
hypertension for at least 6 years, a posterior infarc¬ 
tion 2 years' previously, intermittent claudication for 
several months, and chest and shoulder pain similar to 
that with previous infarction for 3 days. He had an 
increase in chest pain, severe dyspnea, faintness, and 
sweating the day before a.dmission. His course was 
complicated by calf tenderness, increasing dyspnea and 
pulmonary edema and congestion, enlarged tender liver 
and venous distension not controllable by digitoxin, and 
disorientation. He gradually became comatose and extreme¬ 
ly dyspneic and expired on the 33rd day. Cause of death 
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8. P.Me.(B78290) con’t. 
was felt to be recurrent pulmonary emboli but an autopsy 
was not done. EKG’s showed an evolving acute antero- 
septal infarction. WBC was highest (15,000) on clay of 
admission and the peak of his fever was 101° on the 1st 
day. 
F=llj..3; B=0.Lj_: 38 hours after the increase in pain, 
patient was alert and appeared in good 
condition. Temp=100° 
F=l5.0; B«0: 10 days after onset. He was wheezing 
slightly but otherwise in good condition. 
9. M.P. (Ij.55786) , was a 76 year old white woman who had had 
diabetes for 15 years, and a posterior infarction 5 years 
previously, followed by angina and occasional ankle edema. 
She had increasing anginal pain for 3 days before admis¬ 
sion, then a dull ache substernally and in left arm and 
neck, not relieved by nitroglycerin and similar to the 
pain of her previous infarct. She had hypotension and 
slight pulmonary edema on admission. She had no leucocy- 
tosis, but had a fever peak of 102° on the 1st day. 
Serial EKC-? s showed signs of her old infarct and a new 
evolving anterior septal infarct. 
F=9.9; B=1.0: 16 hours after onset of pain, in good 
clinical condition except for temp=101°. 
F=13*0; B=1.2: II4. days after onset, appeared more weak 
and chronically ill than previously, but 
no objective evidence of a change in her 
clinical condition. 
10. M. V. (C454-68), was a 59 year old obese Portugese man with 
a history of hypertension for 10 years angina and several 
episodes of paroxysmal nocturnal dyspnea in the last year. 
He had a burning retrosternal pain, dyspnea, dizziness 
and a feeling of suffocation on the day of admission and 
was found to have a few moist basilar rales and a gallop 
rhythm. He had daily fever peaks of 100° for the first 
week but no leucocytosis. Serial EKG's showed an evolv¬ 
ing anteriolateral infarct. He was discharged after 
17 days. 
F=llj..8; B = 1.2: 18 hours after onset; good clinical 
condition. 
F=9.5; B=.0: 11 days after onset; good clinical 
condition, 
11. C.P. (CL|.9305*‘“Autopsy 11873), was a 63 year old Negro man 
with a questionable infarct [(. months previously. He had 
dull anterior chest pain radiating to the right shoulder, 
but denied other symptoms. On admission he had a gallop 
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11. C. P. ( Cl+9305--Autopsy 11873) con't. 
rhythm, hypotension and sweating. He had no fever or 
leucocytosis on admission. On the 4th day he had a 
psychotic episode, shouting for the police, and on the 
6th day fell out of bed, cutting his scalp. He had 
pneumonia, with bloodjr sputum and fever spikes of 102- 
lo4° from the 10th day until his death on the 33rd day. 
Autopsy showed an old and a recent myocardial infarct, 
pulmonary infarcts, a cerebellar infarct, and a lung 
abscess. Early EKG-'s were suggestive of an acute infarct 
but the typical evolutionary pattern did not occur until 
between the 10th and 20th day. 
Fsl6.£; B=2.1: 38 hours after onset of pain; during 
episode of lethargy and hypotension, 
relieved by demerol. Afebrile. 
F=l8.9; B=8.?: 12 days after onset; pneumonia, temp=101? 
but appearing more alert than before. 
Other cases of acute anterior chest pain: 
Acute Coronary Insufficiency: 
1. A.IT. (635>58“"Autopsy 11883)> was a 64 year old white 
woman with hypertension for 4 years and an infarct 
4 years previously, followed by angina and progressive 
orthopnea. One year previously she had been admitted 
for acute coronary insufficiency without a proved in¬ 
farction, She had 2 weeks of increasing angina, worse, 
on the day of admission, when she also had increased 
sweating, dyspnea, orthopnea, relative hypotension, 
and moist basilar rales. She had a fever of 100° for 
the first 8 days and an eleveated WBC of 12,000 on the 
1st day. She had several bouts of angina during her 
19 days in the hospital. Admission EKG- showed acute 
ischemia and a prolonged P-R Internal, but serial trac¬ 
ings showed no signs of evolving infarct. Pour weeks 
after discharge she had an acute infarction and died 
immediately after admission, probably with ventricular 
fibrillation. Autopsy showed myocardial scarring and 
old and recent coronary occlusion. 
F=5.6; B=3»7: 36 hours after onset of pain, in good 
clinical condition except for a few 
moist basilar rales. 
F=17.6; Bs0,2: 11 days after onset; appeared In good 
condition. 
2. P.L.(440899)1 was an 8l year old white man with an 
Infarct 4 years before, right-sided heart failure for 
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2. P. L. (i|50899) con ’ t. 
2 years, and a leg amputated for gangrene 1 year before. 
He had severe, crushing chest pain, radiating to neck 
and shoulders, nausea, sweating, and suffocation. On 
admission he had occasional gallop rhythm, premature 
ventricular beats and moist basilar rales. His tempera¬ 
ture was 100° for the first six days and spiked to 103° 
on the 7th day. WBC was 15?000 on the 1st and l|.th day. 
Serial EKG’s showed an old posterior infarct and chang¬ 
ing diphasic and inverted T waves, and was suspicious of 
an infarct, but not diagnostic. He was discharged after 
12 days. 
2=27*0; B-2.0: 33 hours after onset, Temp=100°, "alert, 
agile, talkative", 
PslO’.l; B=6.2: 12 days after onset; afebrile but appear¬ 
ed lethargic. 
3. P.Z,(A82615), a 55 year old white man, had angina for 2 
years, with attacks progressing in frequency for the 2 
weeks before admission. He was admitted with severe sub- 
sternal pain, sweating, nausea, and a brief relative 
hypotension. He had slight edema, moist basilar rales. 
He had on admission temperature of 100.5° but was afe¬ 
brile and asymptomatic throughout his uneventful 13 day 
course. Serial EKG's showed depressed S-T segments and 
Inverted T waves, but no changes diagnostic or suggestive 
of acute infarction. 
P=10.8; B=0: 19 hours after onset, in good clinical 
condition. 
P=8.2; B=0: 9 days after onset. In good clinical 
condition. 
i|. A. S, (B13250), was a 53 year old white man with a history 
of an infarct 9 years before with occasional angina after 
wards. He was admitted with a history of increasing 
dyspnea for 3 weeks and persisent angina, orthopnea, and 
moderately severe dyspnea on the day of admission. 
Digitalization and bed rest led to a diuresis and 10 lb. 
weight loss. He was discharged after 7 days, with a 
diagnosis of angina, cardiac insufficiency, and pulmon¬ 
ary edema. Two EKG's were unremarkable. Ho fever or 
leucocytosis. 
P=20.2; B=1.6: 2br hours after onset of pain; markedly 
orthopneic but otherwise in good condition 
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Pulmonary Infarctions: 
5. C.C.(30246), was a 66 year old white man with a 6 year 
history of hypertension and angina for 1| months. Before 
admission he had acute anterior chest pain, dyspnea, and 
sweating. This subsided after 8 hours, and he was free 
of pain for 6 hours, after which he had another similar 
episode with radiation of pain down both arms. He was 
given O2, and his 21 day course was uneventful. Serial 
EKG’s were suggestive of an acute infarction, but were 
obscured by idioventricular complexes. Review of trac¬ 
ings led to EKG diagnosis of pulmonary emboli. He had 
no fever or leucocytosis. 
Frl5.3J B-0: 18 hours after onset of pain; In good 
clinical condition. 
F=5.6; B=0: 15 days after onset; in good clinical 
condition, 
6. J.W. (4184.25) * was a 64 year old white man with a prob¬ 
able infarct 2 years before followed by left bundle 
branch block and pulmonary edema, but not confirmed by 
EKG. He had angina since then and two admissions for 
chest pain and dyspnea without EKG evidence of myocar¬ 
dial infarction. He had lues In 1935> ?x-ray evidence 
of aortitis and a murmur of aortic insufficiency. On 
admission he had acute substernal pain, dyspnea, sweat¬ 
ing slight ankle edema, and a tender enlarged liver. 
He had a history of thrombo-phlebitis 6 months before 
and on admission had palpable calf veins and diffuse 
moist inspiratory rales and expiratory rhonchi. On the 
1st day he had x-ray evidence of a right lower lobe 
pulmonary infarct. He died on the second day with acute 
pulmonary edema. EKG showed ectopic ventricular focus, 
ST-depression and T wave inoersion, WBC was 11,500. 
No fever. No autopsy was done. 
F=l4.3; B=5»6: 12 hours after onset of the pain, patient 
was orthopneic, slightly dyspneic at rest, 
18 hours before death. 
Pulmonary Edema and Trauma: 
7. S.H.(453986), was a 63 year old white man with a history 
of occasional dependent edema, and episodes of dyspnea 
for 5 years, and a fractured arm 5 weeks before admission. 
He was admitted in moderate pulmonary edema with slight 
cyanosis, after being struck by an auto. He had a fever 
of 101° for 7 days and then was afebrile for the rest of 
his 38 day hospital course. He had no leucocytosis. He 
had a moderate anemia and lethargy for his entire course, 
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7. S.H.(453986) con't. 
but no conclusive diagnosis was reached. EKG’s on the 
first 2 days were unremarkable. 
F=28.0; B=0: 5 hours after the accident; temp=101°; 
apathetic and orthopneic. 
F=2.0; B=0: 22 days after onset; apathetic, but no 
clinical findings. 
Anxiety Reaction; ? Gastritis: 
8. D.C.(451376), was a 34 year old white ambulance driver 
with no history suggestive of cardiovascular disease. 
Two days before admission, following heavy drinking, he 
had oppressive retrosternal pain, nausea, and vomiting. 
The physical exam, laboratory studies, EKG, and 2 day 
hospital course were unremarkable. Three days after 
discharge he returned to the outpatient clinic with abdo 
minal discomfort and a history suggestive of a mild 
gastritis. 
F=20.6; B=1.3: 3 days after onset of pain and 1 hour 
after he had been assured he did not 
have a "heart attack”, which he had 
thought had happened. 
Acute Benign Pericarditis: 
9. P.A.(44893)> was a 37 yesr old white man with no history 
of cardiovascular disease. He was awakened by a sharp 
retrosternal pain, aggravated by breathing or leaning 
forward, and a shaking chill. He had had a similar pain 
5 months previously and a respiratory infection 2 weeks 
before. Physical exam, laboratory studies and 13 day 
hospital course were unremarkable. The clinical diagno¬ 
sis was acute benign pericarditis; other causes of peri¬ 
carditis were ruled out. 
Br3-5; B=0.2: 12 hours after onset of pain. 
Cyanosis; Anoxia: 
10. M.W, (449973““Autopsy 11890), was a 43 37-ear old white 
female with a. long history of chronic pulmonary disease 
and a previous episode of CO2 of 37 mEq/L, weakness and 
black outs. She was pub' in a respirator on 3 occasions 
and required a tracheotomy, and thyroid therapy because 
of a butanol-extractible iodine of 1.2 micrograms^. 
She was in critial condition throughout her 35 day course 
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10. M.W. ([|li-9973-“Autopsy 11890) con't. 
with respiratory rates from 20 to 5>0 per minute, CO2 
values from 37 to I4.0 mEq/L, and bouts of cyanosis. 
Autopsy showed pulmonary fibrosis and emphysema, cor 
pulmonale, and a fibrotic thyroid gland. 
P=27.2; BrO.ip: on 2ipth hospital day; slight cyanosis, in 
respirator, blood pressure maintained by 
I.V. nor-epinephrine; CO2 was 39) she had 
received 25 mg. of tri-iodotyrosine once. 
F=26.1; B=2.0: on 31st day, slight cyanosis. Not in 
respirator; comatose, anuric; blood pres¬ 
sure was 60/20, maintained on nor-epine¬ 
phrine. Had had 7 days of tri-iodosine 
therapy. CO2 was 34* Respirations were 
50 per minute. 
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Summary of Laboratory Data 
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+3 -P 
p Ctf o 
© £ CJ 
•H cn Ph 
-P 05 -P 
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Ah Ph © 
© 'O 
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•H Ph 
-P © CO 
O J> <D 
CO O 3 
O O i—1 
•H © CO 
T5 Ph > 
CO 
K Ph pH 
pH 
© TJ 
Ph CO > © 
o © ■H Ph 
•p -P © 
© co O > 
fciO o CO O 
CO *H O O 
Ph rH •H © 
© P-i 'O Ph 
> P CO 
<i T3 Pi PQ 
PQ 
CO 
O
f 
te
s
 
© ® cO 
D W o 
rH CO *H 
CO Ph <H 
> © Ph 
PQ 
> P 
<tj rO 
ml. 1> JU^fo "f 
P. A. (1) 18.5 56.2 2.18 3.5 51 0.4 0.4 
18.5 68.0 1+.92 0 
T.B.(1) 25.0 50.0 12.5 12.5 50 3.6 3.6 
(2) 20.0 ill. 6.9 6.9 88 10.3 10.3 
I.B.(1) 17.5 69.8 19.1 19.7 37 5.7 2.9 
17.5 63.8 20.2 41 0 
(2) 20.0 55.2 19.2 18.1 29 4.15 3.3 
18.0 67.8 17.0 51 3.4 
C.C. (1) 20.0 103. 13.4 68 0 0 
7.0 65.6 17.2 15.3 
(2) i5.o 85.5 4.5 5.6 67 0 0 
15.0 79.5 6,6 68 0 
D.C.(1) 17.1 68.8 '20.9 20.6 69 0 1.4 
17.1 62.2 _ 20.3 76 2.7 
R.E.(1) 20.0 6ip. 5 9.9 8.2 81 2.7 1.7 
20.0 86.5 6.5 72 0.75 
(2) 20.0 90.5 8.5 7.5 69 0 0 
18.5 86.5 6.5 56 0 
S.H.(1) 20.0 96. Lj. 28.0 28.0 99 0 0 
(2) 20.0 55.3 6.9 2.8 50 0 0 
■* Numbers In parentheses refer to the acute (1) and convalescent(2) 
plasma. 
z micrograms / 100 ml. plasma 
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Ph CQ 
0 ©d © ©5 
> © Ph © > © Ph © 
'O •H Pi O © •H P< O © 
© -P 0 W -P -P © © -P 
-P -P O > © © cti O > © © © 
c © o 0 O PS bD © cd o d to O 
0) S ecs O 0 1—1 cd *H o o i—i © «H 
•H w Pi •H © 0 Pi rH •H © cd Pi rH 
-P cd -i-o ©d Pi > © ©d Pi > © a 
© H W i> d cd > d 
Ph Ph 0 PP Ph pH C ©3 CP CQ CQ «aj ©d 
ml. of /0 pj^/o % iwfo 
' j jM-fo 
F. J. (1) 19.0 56,7 15.8 14.6 68 1.0 0.5 
19.0 794 134 70 0 
(2) 20.0 85.0 4*7 5.4 57 0 0 
20.0 63,0 6.0 61 0 
W.K.(1) 17.8 50.7 374 37.9 61 3.2 5.6 
10.0 524 38.4 65 8,0 
(2) 20.0 63.6 16,2 17.2 50 6.4 54 
18.0 72,3 18,1 64 445 
P.L.(1) 19.1 68,7 27.0 27.0 q8 0.3 2.0 
25 3.8 
(2) 25.0 4-0.0 5.9 10,1 65 44 6.2 
25.0 44*3 14.4 46 8,0 
A.M?(1) 15.0 79.5 40, 6 35.3 75 3.7* 5.2* 
15.0 75.6 30,0 68 6.7* 
(2) 15.0 61,6 25.3 27.9 58 0.4-s 0.6* 
15.0 69.6 30,6 64 0.9* 
P.MP(l) 15.5 117 12.3 14.3 74 0 0.4 
16.0 114 16,2 83 0.7 
(2) 21.0 69. s 13.8 15.0 57 0 0 
21,0 70.6 16.3 53 0 
F.M.(1) 21.5 ' 59.5 17,2 17.0 71 4.2 3.3 
21.5 51.6 16,9 43 2,4 
(2) 13,9 49.3 9.9 9.9 % 2.9 1.5 2.2 
A.N.(1) 20.0 27.8 7.5 5.6 43 3.9 3.7 
194 69.5 3*7 53 3.5 
(2) 20.0 85.0 174 17.6 79 04 0,2 
20.0 83.2 17.8 93 0 
-«--Sweat’s method of sulfuric acid fluorescence was used. 
o. 
H* 
cn 
. 
.0 C. . . 
.. X 
. 
. 
. E 
j.vl 
(I 
•1-1. Y. . 
< . o 
. OS 
- +1.VC 
• 
„ •: AI 
0.01 
(I) .7: . Vv 
. ■ • 
# 
. 
s. 
I. .1 
0 . 
. 
. OS 
. 
. 0, Yc • * - 
• i . 0. o.-r , 
. 
. : c ,c4 
, 
♦ 
• ) 
. 
* 
• F. ' 
, ■ 
. • 
. ;I 
. 
r.. X *» i. 
.; . r !' 
e 
. 
M ) : ■;." 
. ' m ^ X . 
, 
• .. 
<i 
. uu 
• • * 
. 
« * — # 
• V. 
« 
4-«iVX 
(I),7.A 
. 
; .yi 
i !y 
« * 
- • • s 
33 
Ph CQ 
© to ® to 
> © «iH CO > © CO 
TO •H in o © •H O © 
© -P © m -P -P © m P 
p -P O > © © CO O > © © © 
& CO o cO O CO bO © cO O CO bO O 
© £ CO O O r—1 cd *h o o i—1 © *H 
•r~l ro © •H © CO U •H © CO © iH 
-P co -p tO © > © a TO © i> © P. 
CO i—l M cO > © CD > © 
Ph Ph © K Pm Ph <! to Cm CQ CQ C TO 
ml. af Jo i¥° /-'P 
of 
■ /» 
C.P.(1) 15.0 82.6 16.5 16.5 64 2.1 2.1 
(2) 14-5 35.1 18.9 13.9 64 8.7 8.7 
M.P.(1) 14.0 71.6 9.7 9.9 65 14* 1.0 
14.0 69.6 10.1 72 0.6 
(2) 20.0 77.3 11.5 13.0 73 0.9 1.2 
20,0 25.3 14.5 29 2.3 
A.S.(1) 17.5 63.8 20.2 20.2 81 3.1 1.6 
17.5 lost 65 0 
M. V. (1) 22.0 69.I 11.5 14.8 74 1.2 1.2 
22.0 68.5 18.2 69 1.2 
(2) 17.5 90.2 10.5 9.5 65 0 0 
17.5 78.7 8.4 55 0 
J.W.(1) 19.4 48.8 14«4 14.3 56 8.1 5.5 
19.4 63.0 14. 2 67 3.0 
M.W.(1) 24.0 55.9 25.2 27.2 82 O.67 0.4 
24.0 62.3 29.2 92 0.21 
(2) 17.0 97.0 23.0 26.1 73 1.8 2.0 
17.0 82.5 29.2 80 2.2 
F.Z.(1) 14.5 64.9 8.9 10.8 87 0 0 
14.5 54.2 12,6 82 0 
(2) 15.0 83.I 6.5 8.2 98 0 0 
15.0 81.8 9.9 90 0 
-::-=Sweat’s method of sulfuric acid fluorescence was used 
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Table 1: Normal Values of Plasma, hydrocortisone and 
corticosterone using Bondy's method,(30,b7a) 
Number of micrograms/100 ml. plasma 
1 Subjects Range Mean Z S.D. 
Hydrocortisone 33 8.1 t 3*6 
(cortisol) 
29 J+-17-7 10,2 1 3.6 
Corticosterone 29 0-5.0 1.3 1 2.5 
. 
S.D. z \f sum of (mean-each value)2 
number of values”— 1 
. 
. 
+• 
(Iooi3*ioo) 
■;. 
.1. 
e 2: Plasma hydrocortisone 
Acute myocardial infarctions: 
Case No. Age & Sex Plasma F in micrograms/100 ml. 
Days after onset 
1 -- 2 10-lk 2k-31 
1. 73M 20 18 
2. 43M 13 7 
3* &3M 15 5 
4* 37M 38 17 
5. 66M 8 8 
6. 5i|M 17 10 
7. 68F-* 35 28 
8. 57M-::- Ik 15 
9* 76P 10 13 
10, 59M 15 10 
11. L 63M* 17 19  ?-- 
Mean t 3.D. 18+10 
j 
12±5 
Gontrol Cases: 
Case No. Age & Sex Plasma F in micrograms/100 ml. 
Days after onset 
1 — 2 10-lii 2[{.-31 
1. 6IjF 6 18 
2. 8lM 27 10 
3* 55m 11 8 
4. 53M 20 — 
5* 66M 15 6 
6, 6i|i?# !k 
7. 63M 28 2 
8. 34m 21 — 
9. 37M k — 
10. IJ.8f-«- 27 26 
Mean ± S.D. 
— — —--—, 16±9 io*5 S i 
fatal cases 
. 
• 
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Plasma corticosterone Table 3: 
Acute myocardial infarctions: 
Case No. Age & Sex Plasma B in micrograms/100 ml. 
Days after onset 
1 — 2 * lO-lli 2k-31 
1. 73M 2.8 3.8 
2. 4.3M 3.6 10.3 
3. 63M 0.5 0 
4* 37M 5.6 5.1i 
! * 66M 1.7 0 
6. 5Um 3.3 2.3 
7. 68p» 5.2 0.6 
8. 57m* 0.I4. 0 
9. 76f 1.0 1.2 
10. 59m 1.2 0 
11. 63M-:j- 2,1 8.7 
Mean i S.D • 2.5*1.8 2.913.8 
_ 
Control Cases: 
Case No. Age oc Sex Plasma B in micrograms/100 ml.) 
Days after onset 
1 — 2 ' IO-D4. 2ij--31 
' 1. 61|P 3.7 0.2 
2. 81M 2.0 6.2 
3. 55m 0 0 
4. 53M 1.6 
c5 
.■ « 66m 0 0 
6. 6I4.M-* 5.6 
7. 63M 0 0 
8, ikx. 1.3 —— 
9. 37M 0.2 ___ 
10. rj.8 p* 0. U-; 2.0 
Mean t S.D . 1.612.0 1.312.8 
0= less than 0.1 
fatal cases 
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Table Lj.: F/B ratio 
F./B ratio 
Acute Convalescent 
Case Diagnosis 1st or 2nd 
day 
10th-31st 
(3 ay 
W.K. Acute M.I. 6.8 3.2 
A.M? It II 6.8 46.5 
M.P. II II 9.9 10.8 
M. V. II II 12.3 (95) 
I.B. I! It 6.8 4.8 
R.E. II II 4.8 (75) 
P.M? It li 35.8 (i5o) 
F. J. It II 29.2 (54) 
T.B. 11 II 3.5 6.7 
F.M. II II 5.2 4.5 
C.P. II II 7.8 2.3 
A.N. Coron. insuff. 1.5 70 
F.Z. it ii (108) (82) 
P.L. tt it 13.5 1.6 
C. C a ii (153) (56) 
A. S. n ti 12.6 
J.W. Pulm. emboli. 2.6 
D. C. Anxiety reation 1.5 —— 
S.H. Trauma & Pulm. edema (280) (28) 
P. A. Benign pericarditis 87.5 
M.W. Chronic pulm. dis. 
with anoxia, shock 
68.0,-13.0 
--.... - * 
If B = 0, It was calculated In all cases as O.J,/u.g.$. 
( ) - calculated from a B value of 0.1 /u.g.%. 
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Table 5: Hydrocortisone and corticosterone levels in patients 
that appeared very critically ill at the time of 
venipuncture. 
Patient Condition at time 
of measurement 
plasma P 
in u.g.Z 
plasma 77 T“ 
in u.g.o 
r ^ ^ r 
T.B. b.p. z 50 by palpation; 
(eventually rose to 110/70) 
no other signs of shock, 
except drowsiness. Adm. EKG 
showed extensive myocardial 
infarct. 
12.3 3.6 | 
1 
W.K. b.p. r 120/100 on I.V. nor¬ 
epinephrine; in 0p tent; 
T=101°. Adm. EKG showed 
extensive infarct. 
37.9 S.6 
A.M? in Op tent; occasionally 
vomiting; T-100°; Adm EKG 
showed severe infarct with 
repeated bouts of premature 
beats and ventricular tachy- 
cardia.s. 
1 
35.3 5.2 
M.W. slightly cyanotic; in res¬ 
pirator; b.p. maintained by 
I.V. nor-epinephrine. 
27.2- 0.4 
ii it b.p. 60/20 on I.V. nor¬ 
epinephrine : anurlc and coma¬ 
tose; slightly cyanotic, not 
in respirator. 
26.1 . 2.0 
C.P. during episode of unrespon¬ 
siveness and hypotension 
(rapid soft pulse, b.p. 80/ 
20) pitting edema of arms 
and legs. 
16.5 2.1 
Mean ± S.D. 
-—.— --—~ 
25.10.0' 3.3 ± 2.1 
Mean of all other values 
in this study 
14 ± 7 2.0 i 2.6 
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Table 6: Nine hydrocortisone and corticosterone determinations 
In the five fatal cases 
Case Remarks Iplasma F 
[in u. g.$ 
plasma 3 
in u.g./o 
A.M? 
68F 
myocard. Infart.; Ilf. hours 
after onset. 
35.3 i 5-2 
M If 
l 
24 days after onset; 5 days 
before death from ventric. 
fibrillation. 
27.9 0.6 
P.M? 
57M 
myocard. infarct,; 36 hours 
after onset. 
14.3 0.4 
; M 1! 10 days after onset; 23 days 
before death from recurrent 
14.0 <0.1 
; pulm. emboli. 
! 
! C.P. 
i 63M 
myocard, infarct; 38 hours 
after onset. 
16.5 2.1 
tt 11 12 days after onset during 
bout of pneumonia; 21 days 
before death from lung ab¬ 
scess and pulm. infarcts. 
18,9 1 8.7 
•J.W. 
6I(JVI 
Pulm. infarcts.; 12 hours 
after onset; 18 hours before 
death; in acute pulm. edema. 
14.3 5.6 
M.W. 
48P 
chronic pulm. Insufficiency 
hypothyroidism; 24.th hosp. 
day; in shock, cyanotic. 
27.2 0.4 
II II 4 days before death from res¬ 
piratory and right heart fail¬ 
ure; in shock, comatose. 
26.1 2.0 
_ 
Mean ± S.D. 
■" r ■ ■ |ji 
21.8 ± 7.8 2.8 ± 3.0 
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Discussion 
4-0. 
Hydrocortisone values (Table 2.): 
The mean plasma hydrocortisone level for myocardial 
infarctions and for control cases did not differ significantly 
from each other in the first two days of hospitalization. 
There were two cases of myocardial infarction with high hydro¬ 
cortisone levels of 35> and 38 hut these were severe 
infarctions which presented no diagnostic problem in the 
original clinical examination and electrocardiogram. In nine 
cases in which the diagnosis was doubtful in the first three 
days of the illness, the plasma hydrocortisone levels in this 
early period ranged from 6-28 /a.g.$, with two non-infarcts 
having the two highest values: 
Non-infarcts Infarcts 
case F level case F level 
C.C 15 I.B. 20 
P.Z. 11 M.P. 10 
A. N. 6 P.M? 14 
P.L. 2? 
S.H. 28 
J.W. 14 
Thus, in this series, the plasma hydrocortisone levels were not 
useful in establishing the early diagnosis of myocardial In¬ 
farction in doubtful or borderline cases. 
The mean value for plasma hydrocortisone in 62 normal 
healthy individuals was 9.1 i 3«6/ufg.$ (Table 1.), The mean 
values for both infarcts and controls were significantly 
l i iC 
,S. 
. . 
. 
, " ■ ,.x» 
elevated during the acute phase of the illness, and were almost 
double the normal mean value. After ten days of hospitaliza¬ 
tion, presumably during a period of convalescence, both the 
mean control and infarct hydrocortisone levels were only slight 
ly elevated above the normal mean. This suggests that, in 
general, hydrocortisone levels are high in the acute phases of 
a disease and fall to normal during convalescence. 
In nine determinations done on five patients who died of 
their disease, four of the hydrocortisone levels were above 
26 p.g.%, but four were within the normal range of Ip—18 id.g.%. 
(Table 6) The level found in the determination made nearest to 
the time of death was lij..3 j-i. g. $, done eighteen hours before 
death of acute pulmonary edema. Most of the fatal cases ter¬ 
minated suddenly. Only one case (M.W.) corresponded to the 
group of chronically ill, slowly dying patients who had high 
plasma 17-hydroxycorticosteroids values immediately before 
death. (63) Se veral non-fatal cases also had high values, so 
the hydrocortisone level was not useful in predicting which 
cases would be fatal. 
During the early acute phase of the two cases of myocardi¬ 
al infarction previously mentioned, the hydrocortisone levels 
above 35 corresponded to a very severe clinical condition 
However, the values were within the normal range of Ip-lS^u.g,^ 
in two other cases of acute infarction that were also in a 
critical clinical condition at the time the blood 'was drawn. 
(T.B.; C.P.--See Table 5) One subnormal value of 3,5 p.,g,% 
was obtained 12 hours after the onset of the acute pain of 
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acute benign pericarditis, A high value of 20.6 h.g.$ was 
found in a case of "cardiac anxiety". Hence we can conclude 
that the hydrocortisone level during the acute phase of an 
illness is elevated as a rule, although not always to a degree 
consistent with the clinical severity. 
F/B ratio (Table Lj-» ) ‘ 
The hydrocortisone/corticosterone ratios in these patients 
showed a wide range--from 1,5 to 280, If those values of cor¬ 
ticosterone which were 0.1 or less are excluded, the range 
of all the F/B ratios was 1.5 to 87.5> and the median and the 
mode were both 6.8. The F/B ratio for a given individual was 
not constant, and there was no inverse dissociation of the hydro¬ 
cortisone and corticosterone levels as suggested by Elman.(73) 
The actual level of corticosterone in the plasma seems to be a 
more useful figure than the F/B ratio. 
Corticosterone values (Table 3*)* 
The mean values of plasma corticosterone were lower than 
the mean values for hydrocortisone. The range of plasma corti¬ 
costerone was from zero to 10.3 p.g.%, In all determinations 
in which levels of zero (less than 0.1 were found, the 
added labelled corticosterone was recovered in good proportion. 
The mean corticosterone value In the acute phase of eleven 
infarcts was 2.5 ±1.8 n.g.%, compared with a normal mean of 
1.3 ± 2.5 in 29 normal persons. No myocardial infarction in 
the acute phase had a corticosterone level of zero, although 
this hormone was often not detected in other situations. 
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The mean value in 6 determination of Compound B in situations 
in which the patient appeared very critically ill at the time 
the blood was drawn was 3.8 ± 2.1 u.g.$--which is significantly 
higher than the normal mean (P>.02), but not significantly 
higher than the mean of all the other corticosterone values 
measured in this series. The mean Compound B value in the acute 
phase of infarction was also not significantly higher than the 
mean of all other B values in this series. The three highest 
plasma corticosterone values (6.2, 8,7? and 10.3 u.g.$) were 
all found at least ten days after admission to the hospital. 
On the basis of these experiments it can be concluded that 
in the early stages of a myocardial infarction and during a 
time when a patient clinically appears critically ill, cortico¬ 
sterone is not significantly elevated above the level which 
might be found at any other time in the course of the same hos¬ 
pitalized patient. One explanation for this finding is that an 
acute illness does not increase the secretion of corticosterone 
by the adrenal cortex. An alternative explanation is that be¬ 
cause of the rapid disappearance of corticosterone from the 
blood stream, no elevation or only a transient elevation of 
plasma level occurs. This disappearance might be due to in¬ 
creased reduction or conjugation or more rapid utilization of 
corticosterone during "stress". It is also possible that blood 
samples were not obtained soon enough after the onset of the 
acute illness to detect any elevated corticosterone levels which 
may have been present. Nevertheless, if the stimulus for adren¬ 
al secretion of corticosterone occurs repeatedly during the 
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first 21\. hours of an acute Illness, we might have expected to 
find at least one very high corticosterone value among the 
determinations made during this acute period. 
Many more plasma, corticosterone determinations in various 
clinical situations and more experiments on the conjugation 
and utilization of corticosterone by humans will be necessary 
to determine conclusively the stimulus for secretion and the 
function of this hormone in man. 
t n o 9L' ■ V 917.: / 8.0 C1 $*100 £fe ri Y*Te • 9|PL 3 B&65#» jH-t 
‘ 6 
f.rli rro ' . nsrri'ioqxs 0*100? fens *soJ lao-Xni.Co 
Rnsmurl T:'i ono^o^eo 
?. l' : c.r a ev'i vlevJt^-iOnoo ealmcs^b oct 
. .tx 0 :: ri - : i :o 
45. 
Summary 
1. The general problems of the rationale, methods, and 
significance of the measurement of plasma adrenocor¬ 
tical hormones are discussed. 
2. The history of the methods of measuring the function of the 
adrenal cortex is outlined, with particular emphasis on 
the evolution of the technique used in this thesis. 
3. The results of other clinical studies on plasma levels of 
hydrocortisone (Compound P) and corticosterone (Compound 
B) and on adrenal cortical function in myocardial in¬ 
farction are summarized. 
4. The plasma hydrocortisone and corticosterone levels were 
measured in 21 patients—11 with EKG-proved acute myo¬ 
cardial infarctions and 10 control cases with acute 
chest pain from other causes. 
5. The mean hydrocortisone levels were elevated to about the 
same degree in the acute phases of the myocardial in¬ 
farction and the controls: 18 ± 10 and 16 ± 9 /U.g./o 
respectively, with a normal value in this laboratory of 
9.1 i 3*6/U.g.%* After 10 days in the hospital, the 
values fell to near normal levels in both infarcts and 
controls. 
6. It was concluded that the plasma hydrocortisone level is of 
little value in distinguishing which patients will die 
or in distinguishing which patients have myocardial 
infarcts if there is a difficult problem*of differential 
diagnosis. In general, the hydrocortisone levels are 
normal in convalescence and elevated in the acute phase 
of an illness to a degree proportional to the clinical 
severity of the disease, although there were a few 
exceptions, 
7. The F/B ratios showed a v/ide range with no regular patterns, 
and it was concluded that this ratio is a less useful 
measurement than actual Compound B levels. 
8. The mean corticosterone level in the acute phases of myo¬ 
cardial Infarctions was 2.5 ± 1.8/u.g.^; in six selected 
determinations where the patient appeared critically ill, 
3.8 ± 2.1; in all other cases except these last six, 
2.0 ± 2.6; and in normal persons, 1.3 i 2.5 yu.g.$. 
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9. It was concluded that the plasma corticosterone level in 
acutely ill patients is not elevated above those values 
which might be found at any other time in the patient’s 
hospital course. This absence of elevated corticosterone 
levels may be due to absence of increased secretion 
during acute illness or to rapid disappearance from the 
blood stream due to increased conjugation or utilization. 
* 
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